Delivery Order SPE2DR25D3014-SPE2DR26FP1YP
Award Date 2/17/26
Potential Completion Date 2/18/26
Potential Value $4.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $15,439.02 delivery order to AmerisourceBergen Drug Corp on February 12, 2026, for Repatha 140 mg/ml SureClick auto-injector pharmaceutical product. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, which supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is...
- The Defense Logistics Agency issued a $22,568.95 delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for Repatha 140 mg/ml SureClick auto-injector pharmaceutical supply. Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 10, 2026, and is priced on a firm fixed-price basis with no set-aside. The delivery order is issued under the parent IDC held by Amerisourcebergen Drug Corp with DLA Troop Support Medical, a comprehensive global...
- The Defense Logistics Agency issued a $18,428.82 delivery order to AmerisourceBergen Drug Corp on February 13, 2026, for Repatha 140 mg/ml SureClick auto-injector pharmaceutical product. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 running through December 2026, which enables supply of pharmaceutical products and medical supplies to military healthcare programs worldwide. Place of...
- The Defense Logistics Agency issued a $16,509.75 delivery order to AmerisourceBergen Drug Corp on February 12, 2026, for Repatha 140 mg/ml SureClick auto-injector pharmaceutical supply. The order is issued under the DLA Troop Support Medical IDC held by Cencora, Inc. (parent of AmerisourceBergen Drug Corp), a $999,999,999 indefinite delivery contract through December 2026 supporting comprehensive global pharmaceutical supply to military healthcare programs. Place of performance is...
- The Defense Logistics Agency issued a $16,437.18 delivery order to AmerisourceBergen Drug Corp on February 17, 2026, for REPATHA 140 mg/ml SureClick auto-injector pharmaceutical product. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), an indefinite delivery contract vehicle valued at up to $999,999,999 and running through December 2026, supporting global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, PA. The ultimate...
- <p>The Defense Logistics Agency issued a $4,255.06 delivery order to Amerisourcebergen Drug Corp on February 13, 2026, for Repatha 140 mg/ml SureClick auto-injector pharmaceutical supply.</p> <p>Place of performance is Conshohocken, PA. The ultimate completion date is February 17, 2026. The order carries firm fixed pricing and was issued with no set-aside.</p>
- <p>The Defense Logistics Agency issued a $1,646.28 delivery order to Amerisourcebergen Drug Corp on February 11, 2026, for Repatha 140 mg/ml SureClick auto-injector pharmaceutical supply with ultimate completion on February 12, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is issued under a firm fixed-price structure with no set-aside applied.</p>
- The Defense Logistics Agency awarded a $4,103.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, which is a child order under AmerisourceBergen's parent company Cencora, Inc., carries an ultimate completion date of January 7, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order was awarded through open competition with...
- The Defense Logistics Agency awarded a $4,540.44 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract represents a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and was awarded without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded a $4,888.56 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 9, 2026. The product will be delivered to the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction executed under AmerisourceBergen's...
- SPE2DR25D3014Indefinite Delivery Contract
- SPE2DR25D3014-SPE2DR26FP1YPDelivery Order
The Defense Logistics Agency issued a $4,093.30 delivery order to AmerisourceBergen Drug Corp on February 17, 2026, for Repatha 140 mg/ml SureClick auto-injector pharmaceutical supply. The order is issued under the parent IDC held with DLA Troop Support Medical, a $999,999,999 indefinite delivery contract through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with an ultimate completion date of February 18, 2026.
Generated 5/18/26, 9:48 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 2/16/26 |